Medidata Becomes First Company to Offer End-to-End, Unified, Secure Platform for Decentralization of Clinical Trials (DCT) ...Middle East

Devdiscourse - Opinion
Medidata Becomes First Company to Offer End-to-End, Unified, Secure Platform for Decentralization of Clinical Trials (DCT)
• The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end decentralization for sponsors and CROs • The unique Medidata Trial Dial™ concept provides the industry's highest level of customization for clinical trial decentralization - enabling fully decentralized or hybrid studies SINGAPORE, June 16, 2021 /PRNewswire/ -- Medidata, a Dassault Systèmes company, today announced the launch of the Medidata Decentralized Clinical Trials (DCT) Program, the most comprehensive set of unified, secure technologies that enable full decentralization across the clinical trial continuum. For the first time ever, drug, va

Hence then, the article about medidata becomes first company to offer end to end unified secure platform for decentralization of clinical trials dct was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Medidata Becomes First Company to Offer End-to-End, Unified, Secure Platform for Decentralization of Clinical Trials (DCT) )

Apple Storegoogle play

Last updated :

Also on site :



Latest News